✦ LIBER ✦

CFTR gene mutations in pancreatitis: Frequency and clinical manifestations in an Austrian patient cohort

✍ Scribed by Heinz Zoller; Margit Egg; Ivo Graziadei; Marc Creus; Andreas R. Janecke; Judith Löffler-Ragg; Wolfgang Vogel

Book ID: 106172269
Publisher: Springer Vienna
Year: 2007
Tongue: English
Weight: 172 KB
Volume: 119
Category: Article
ISSN: 0043-5325
DOI: 10.1007/s00508-007-0849-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutations in HAMP and HJV genes and thei

Mutations in HAMP and HJV genes and their impact on expression of clinical hemochromatosis in a cohort of 100 Spanish patients homozygous for the C282Y mutation of HFE gene

✍ Albert Altès; Vanessa Bach; Angels Ruiz; Anna Esteve; Jordi Felez; Angel F. Rema 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 114 KB

Mutation analysis of the cystic fibrosis

Mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the cationic trypsinogen (PRSS1) gene, and the serine protease inhibitor, Kazal type 1 (SPINK1) gene in patients with alcoholic chronic pancreatitis

✍ Perri, Francesco; Piepoli, Ada; Stanziale, Pietro; Merla, Antonio; Zelante, Leop 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 93 KB

Presenilin 1 gene mutation (M139I) in a

Presenilin 1 gene mutation (M139I) in a patient with an early-onset Alzheimer’s disease: clinical characteristics and genetic identification

✍ Hee-Jin Kim; Hyun Young Kim; Chang-Seok Ki; Seung Hyun Kim 📂 Article 📅 2010 🏛 Springer Milan 🌐 English ⚖ 139 KB

Drug resistance mutations and newly reco

Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: Prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients

✍ Carlo Torti; Eugenia Quiros-Roldan; Laura Monno; Andrea Patroni; Annalisa Saraci 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

## Abstract This study aimed at identifying HIV‐1 protease amino acid changes associated with protease inhibitor (PI) exposure and susceptibility. New amino acid substitutions were correlated with the number of experienced PIs, reaching statistical significance only for those at positions 3, 44, an